Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

Meijer Announces New Affordable Access to GLP-1 Medications

prnewswire.com
NVO

Pfizer Becomes Newest Partner Added to BaseLaunch's Biotech Venture Incubator

prnewswire.com
PFE ABBV NVO JNJ CSL CRL

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

globenewswire.com
NVO

New Targets at the Wyloo Gold – Silver – Antimony Project for Maiden Drill Program

globenewswire.com
NVO

Novo Nordisk A/S - share repurchase programme

globenewswire.com
NVO

Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®

globenewswire.com
NVO HIMS

Google Reclaims No. 1 Spot at the 2026 Kellogg School Super Bowl Advertising Review

prnewswire.com
GOOGL COIN AMZN MSFT META NVDA LLY NVO TMO CHTR

Process Analytical Technology Market to Reach US$ 7,828.0 Million by 2030 Driven by Real-Time Process Monitoring, Quality by Design (QbD), and AI-Enabled Continuous Manufacturing | Astute Analytica

globenewswire.com
RCL NVO

Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers' hands

prnewswire.com
NVO

PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026

globenewswire.com
NVO HIMS